Continuous glucose monitor in stroke with diabetes
Part of Brain & nervous system, Heart & circulation, Hormones & metabolism clinical trials.
This study tests a continuous glucose monitor (CGM), a small sensor that tracks your blood sugar, in people who had a stroke and also have diabetes or high blood sugar. The goal is to see how well the sensor works and if it helps manage blood sugar during recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You had an acute ischemic stroke (a stroke caused by a blocked blood vessel in the brain) and received a clot-removal procedure (called endovascular therapy).
- You have type 2 diabetes or high blood sugar (for example, a blood sugar reading over 200 mg/dL or an HbA1c of 6.5% or higher).
- You are not pregnant and do not have severe skin problems on the arm (the sensor is placed on the skin).
- You are not on dialysis, do not have severe kidney disease, and are not expected to be in the intensive care unit during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether using a continuous glucose monitor (a small sensor that checks blood sugar levels around the clock) can help people who were just diagnosed with type 2 diabetes manage their blood sugar better. If you join, you would wear the sensor for a while and get regular feedback, which might help you learn how food and habits affect your sugar levels.
This study looks at using a continuous glucose monitor (a small sensor that tracks blood sugar all day) in people with type 2 diabetes who are not taking insulin. It aims to see if using the monitor helps improve blood sugar control.
This study looks at how people with diabetes feel about using a continuous glucose monitor (CGM) and their blood sugar readings. It aims to learn what works best for patients and healthcare providers to improve diabetes care.
This study compares two ways of tracking blood sugar in people with type 2 diabetes who use insulin. It aims to see if one method helps manage glucose better, which could improve daily control and long-term health.
This study tests using a continuous glucose monitor (a small sensor that checks blood sugar all the time) to help guide the dose of insulin given through an IV. This is for patients who are not in the ICU but need insulin therapy for over a day, especially those on steroids or special nutrition.
This study tests whether using a small sensor (continuous glucose monitor) to check your blood sugar while you're in the hospital can improve diabetes management. You'll wear the sensor for a few days and may not need as many finger-prick tests.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.